Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Integrative Systems

GABA Receptors on Orexin and Melanin-Concentrating Hormone Neurons Are Differentially Homeostatically Regulated Following Sleep Deprivation

Hanieh Toossi, Esther del Cid-Pellitero and Barbara E. Jones
eNeuro 31 May 2016, 3 (3) ENEURO.0077-16.2016; https://doi.org/10.1523/ENEURO.0077-16.2016
Hanieh Toossi
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther del Cid-Pellitero
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara E. Jones
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Barbara E. Jones
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Though overlapping in distribution through the hypothalamus, orexin (Orx) and melanin-concentrating hormone (MCH) neurons play opposite roles in the regulation of sleep–wake states. Orx neurons discharge during waking, whereas MCH neurons discharge during sleep. In the present study, we examined in mice whether GABAA and GABAB receptors (Rs) are present on Orx and MCH neurons and might undergo differential changes as a function of their different activities following sleep deprivation (SD) and sleep recovery (SR). Applying quantitative stereological image analysis to dual-immunofluorescent stained sections, we determined that the proportion of Orx neurons positively immunostained for GABAARs was significantly higher following SD (∼48%) compared with sleep control (SC; ∼24%) and SR (∼27%), and that the luminance of the GABAARs was significantly greater. In contrast, the average proportion of the MCH neurons immunostained for GABAARs was insignificantly lower following SD (∼43%) compared with SC (∼54%) and SR (56%), and the luminance of the GABAARs was significantly less. Although, GABABRs were observed in all Orx and MCH neurons (100%), the luminance of these receptors was differentially altered following SD. The intensity of GABABRs in the Orx neurons was significantly greater after SD than after SC and SR, whereas that in the MCH neurons was significantly less. The present results indicate that GABA receptors undergo dynamic and differential changes in the wake-active Orx neurons and the sleep-active MCH neurons as a function of and homeostatic adjustment to their preceding activity and sleep–wake state.

  • GABAAR
  • GABABR
  • homeostasis
  • mice
  • waking

Significance Statement

The activity of single neurons is regulated in a homeostatic manner such that prolonged activity results in decreased excitability. Orexin neurons discharge during waking, whereas MCH neurons do so during sleep. Here, we examined whether the inhibitory GABA receptors (Rs) on Orexin and MCH neurons would change differentially as a function of their different activities following sleep deprivation and sleep recovery. Whereas GABAAR and GABABR immunostaining appeared to increase on Orexin neurons, it appeared to decrease on MCH neurons after sleep deprivation relative to sleep control and sleep recovery. GABA receptors thus undergo differential changes on Orx and MCH neurons as a function of and homeostatic adaptation to their different activities during waking and sleep.

Introduction

Orexin (Orx) and melanin-concentrating hormone (MCH) peptides are contained in distinct though codistributed neurons in the hypothalamus (Bittencourt et al., 1992; Broberger et al., 1998; de Lecea et al., 1998). From multiple lines of evidence, they appear to play opposite roles in the regulation of waking and sleep. Pre-pro-Orx knock-out mice present with a syndrome of narcolepsy with cataplexy, marked by the sudden passage from waking to REM sleep with muscle atonia (Chemelli et al., 1999). Humans having narcolepsy with cataplexy have a reduced number of Orx neurons or an absence of its peptide in CSF (Peyron et al., 2000; Thannickal et al., 2000). In rats, Orx neurons fire maximally during waking and become virtually silent during sleep (Lee et al., 2005), and they express c-Fos, a marker for neuronal activity, following sleep deprivation (SD) and not sleep recovery (SR; Modirrousta et al., 2005). In contrast, MCH neurons do not fire during waking, but fire sparsely during slow-wave sleep (SWS) and maximally during REM or paradoxical sleep (PS) (Hassani et al., 2009), and they do not express c-Fos after SD but do so after SR (Verret et al., 2003; Modirrousta et al., 2005). We queried whether the different discharge profiles of the Orx and MCH neurons would be associated with different homeostatic responses of those neurons to SD.

Neuronal activity is regulated in a homeostatic manner such that increases in activity are compensated for by decreases in excitability and decreases in activity by increases in excitability (Turrigiano, 1999). These changes are mediated in part by changes in receptors to the inhibitory neurotransmitter GABA, as well as by reciprocal changes in those to the excitatory neurotransmitter, glutamate (Turrigiano et al., 1998; Kilman et al., 2002; Marty et al., 2004). With the knowledge that Orx neurons are active, whereas MCH neurons are silent during continuous waking with SD, we thus examined whether the changes in activity that occur in those neurons would be associated with differential changes in the receptors to GABA. Through in vitro studies, it is known that Orx neurons are hyperpolarized and inhibited by both GABAA (eg, muscimol) and GABAB (eg, baclofen) receptor agonists and that MCH neurons are inhibited by GABAAR agonists (Eggermann et al., 2003; van den Pol et al., 2004; Xie et al., 2006). We thus investigated whether homeostatic changes in response to state specific prolonged activity or absence thereof would be evident in GABAAR and GABABR immunostaining following SD and SR in the Orx and MCH neurons.

Materials and Methods

All procedures were done in accordance with the Canadian Council on Animal Care and were approved by the McGill University Animal Care Committee.

Animals

Male adult mice (n = 25; C57BL/6, 20–25g) were received from the supplier (Charles River Laboratories) and housed individually in cages, which were maintained at an ambient temperature of 22°C, in a 12 h light/dark cycle (lights on from 7:00 A.M. to 7:00 P.M.) and they were given ad libitum access to water and food. Animals were maintained in their home cages for the duration of the experiment and therein recorded by video alone (VM; n = 13) or by video plus telemetry (VTM; n = 12). For telemetric recording of the electroencephalogram (EEG), a transmitter (F20-EET, Data Sciences International) was implanted subcutaneously along the flank and connected to two EEG electrodes placed symmetrically over parietal cortex and two reference electrodes placed over the cerebellum. Following surgery, the mice were allowed 1 week to recover.

Sleep deprivation and recovery experimental procedures

As employed in another study (del Cid-Pellitero, Plavski, Mainville and Jones, unpublished observations), four experimental groups of mice were processed: (1) sleep control (SC), having undisturbed sleep and waking for 2 h from ∼2:00 to ∼4:00 P.M. (∼ZT 7–9; n = 7); (2) SD, being submitted to 2 h of SD from ∼2:00 to ∼4:00 P.M. (∼ZT 7–9; n = 6); (3) SD, being submitted to 4 h of SD from ∼12:00 to ∼4:00 P.M. (∼ZT 5–9; n = 5); and (4) SR, being subjected to 4 h of SD from ∼10:00 A.M. to ∼2:00 P.M. followed by 2 h SR from ∼2:00 to ∼4:00 P.M. (∼ZT 7–9; n = 7). SD was performed by preventing mice from going to sleep by stimulation of the whiskers with a soft paintbrush. For scoring of sleep and waking, mice were recorded by VM for behavior (n = 13) or by VTM for behavior with EEG (n = 12) using HomeCageScan software (3.0; Clever Systems). At the end of the experimental period ∼4:00 P.M. (∼ZT 9), the mice were immediately anesthetized with sodium pentobarbital (Euthanyl, 100 mg/kg; Bimeda-MTC Pharmaceutical). Brains were fixed by transcardial perfusion with 30 ml saline followed by 200 ml of 3% paraformaldehyde. The brains were removed and placed for 1 h in 3% paraformaldehyde for postfixation at 4° C, transferred to 30% sucrose solution for cryoprotection at 4° C for 2 d, and then frozen and stored at −80° C.

Immunohistochemical processing

Brains were cut and processed in batches of two to four, which included mice from SC, SD, and/or SR groups of the same experimental session or period. Coronal sections were cut on a freezing microtome at 20 μm thickness through the diencephalon. Adjacent series of sections were collected at 200 μm intervals for immunohistochemical staining. Free-floating sections were rinsed in 0.1m trizma saline buffer, pH 7.4, and then incubated in 6% normal donkey serum buffer for 30 min and subsequently incubated overnight at room temperature in a buffer containing 1% normal donkey serum with combinations of two primary antibodies: goat anti-MCH (1:250; Santa Cruz Biotechnology, Catalog #sc-14507, RRID: AB_2166711) or goat anti-Orx (1:500; Santa Cruz Biotechnology, Catalog #sc-8070, RRID: AB_653610) with mouse anti-GABAAR β-chain [1:100; clone BD17, Millipore (Chemicon), Catalog #MAB 341, RRID: AB_2109419] or guinea pig anti-GABABR1 [1:2500; Millipore (Chemicon), Catalog #AB1531, RRID: AB_2314472]. Both the GABAAR β-chain and GABABR1 antibodies were produced and characterized years ago and have since been in use over many years (Fritschy and Mohler, 1995; Wan et al., 1997; Nusser et al., 1998; Bonino et al., 1999; Margeta-Mitrovic et al., 1999; Filippov et al., 2000; Straessle et al., 2003). Subsequently, sections were incubated at room temperature for 2 h in appropriate combinations of cyanine-conjugated (Cy3 or Cy5) secondary antibodies from donkey (Jackson ImmunoResearch Laboratories): Cy5-conjugated anti-goat (1:800; Catalog #705-175-147, RRID: AB_2340415) with Cy3-conjugated anti-mouse (1:1000; Catalog #715-165-150, RRID: AB_2340813), or Cy3-conjugated anti-guinea pig (1:1000; Catalog #706-165-148, RRID: AB_2340460). After rinsing the sections with trizma saline, sections were stained with green fluorescent Nissl stain (FNS; 1:2000; Molecular Probes, Catalog #N-21480) for 20 min. Finally, sections were rinsed, mounted, and coverslipped with glycerol.

Image analysis

Triple-stained sections were viewed with a Leica DMLB microscope equipped with fluorescence filters for excitation and emission of Cy2, Cy3, and Cy5 dyes, a digital camera (Orca-R2, C10600-10B, Hamamatsu Photonics KK) and an x-y-z movement-sensitive stage. Images were acquired from three sections in each series (with 200 μm intervals between sections) through the Orx and MCH neurons in the tuberal hypothalamus using StereoInvestigator software (MicroBrightField). With the optical fractionator probe for unbiased sampling and counting, contours were first traced with a 5× objective around all the Orx or MCH neurons in each section within the lateral hypothalamus, perifornical area, dorsomedial nucleus, and/or zona incerta (Modirrousta et al., 2005). For sampling, a grid size of 250 × 150 μm2 was used over each contour, and for cell counting and measurements, a counting frame of 120 × 120 μm2 was used and placed within each rectangular space by the program. In these, multichannel image stacks were acquired under a 40× objective and were comprised by optical sections of 0.5 μm thickness through the mounted histological section of ∼15 µm thickness. Within these images, the tops of all cells located <1 µm from the surface of the section were counted, thus through 14 µm of the section within the counting frame. Across the three sections, ∼38 counting frames for Orx neurons and 59 for MCH neurons were acquired and analyzed per series. With this sampling, the average number of Orx+ cells counted across series on one side was 56.6 ± 0.70 (mean ± SEM), corresponding to an estimated total number of 1559 ± 70 Orx+ neurons within one side of the tuberal hypothalamus of the mouse. The average number of MCH cells counted was 83.96 ± 0.80, corresponding to an estimated total number of 2364 ± 86 MCH+ neurons. By moving through the z-plane, the double-labeling of the cells for the GABAA receptors (Rs) on the membrane or GABABRs in the cytoplasm was determined. Estimated total numbers of double-labeled cells were computed for each series (GABAAR-Orx or GABAAR-MCH in 12 VTM and GABABR-Orx or GABABR-MCH in 13 VM) and expressed as percentage of Orx+ or MCH+ cell populations per series.

Luminance measurements were performed on the Orx+ and MCH+ cells that had been counted as positively stained for GABAAR or GABABR in the images randomly acquired and counted using Optical Fractionator (above). So as to analyze similar numbers across groups, 8–10 double-labeled Orx+ or MCH+ cells, which were present in all animals, were analyzed per animal. The images had been acquired under the same gain and exposure for each series using an 8 bit setting of the digital camera to yield arbitrary units between 0 and 256 in the converted grayscale of the fluorescent images. To measure the luminance of the receptors, different approaches were used for the GABAARs concentrated over the plasma membrane versus the GABABRs located in the cytoplasm as well as over the membrane. For membrane GABAARs, a box of 1.5 × 0.3 μm2 was placed over the membrane and another over the nucleus to measure and subtract background staining in each cell. For membrane plus cytoplasmic GABABRs, a donut-shaped contour was drawn around the cytoplasm and plasma membrane, and another traced around the nucleus to measure and subtract background staining in each cell.

Cell counts and luminance measurements were analyzed between experimental groups for each cell type (Orx or MCH) and receptor (GABAA or GABAB) using one-way ANOVA for main effect of group followed by post hoc paired-comparisons with Tukey’s HSD correction for differences between groups (SYSTAT Software, v13; Table 1). Given that there was no significant difference between the two SD 2 h and 4 h groups, they were combined into one SD group.

View this table:
  • View inline
  • View popup
Table 1.

Summary of statistics

Sections were also viewed and images acquired for this publication with an LSM 710 confocal laser-scanning microscope equipped with Ar 488 nm, He-Ne 543 nm, and He-Ne 633 nm lasers for excitation and emission of Cy2, Cy3, and Cy5 dyes. Image stacks were acquired under 63× oil objective (1.4 numerical aperture, 0.5 μm thickness for each optical section) with a 1.0 airy unit pinhole size for each channel. All figures were prepared and composed in a consistent manner for brightness and contrast across groups using Adobe Creative Suite (vCS4).

Results

Sleep–wake states across groups

Mice were prevented from falling asleep in the SD group (n = 11) and were thus continuously awake, whereas those in the SC group (n = 7) and SR group (n = 7) were awake for only a small percentage of the time during the 2 h prior to termination at ∼4:00 P.M. (Fig. 1A; Table 1). After having been previously sleep deprived, mice in the SR group were awake less or reciprocally asleep significantly more of the time (92.61 ± 2.21%, mean ± SEM) than the SC mice (76.77 ± 2.56%), indicating a homeostatic response to SD. Mice in SC and SR groups spent the majority of time in NREM sleep (66.93 ± 1.71%, n = 3 and 82.29 ± 4.07%, n = 3, respectively) and minimal time in REM sleep (9.28 ± 0.89%, n = 3 and 12.03 ± 0.87%, n = 3, respectively). Both NREM and REM sleep were significantly increased during SR relative to SC (del Cid-Pellitero, Plavski, Mainville and Jones, Unpublished observations).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Sleep–wake states and GABA receptors in Orx and MCH neurons across groups. A, Percentage of time spent in wake during the 2 h preceding termination in SC, SD, and SR groups. Percentage wake is significantly higher in SD compared to SC and SR and significantly lower in SR compared to SC. B, Proportion of Orx+ or MCH+ neurons bearing GABAARs across groups. The percentage Orx+/GABAAR+ was significantly greater in SD compared to SC and SR (B1), whereas the percentage MCH+/GABAAR+ neurons was insignificantly less in SD compared to SC and SR (B2). C, Luminance of the GABAAR immunofluorescence on Orx and MCH neurons across groups, which was significantly increased on the Orx+ neurons (C1) and decreased on the MCH+ neurons (C2) in SD compared to SC and SR. D, Proportion of the Orx (D1) and MCH (D2) neurons expressing GABABRs, which did not change across groups. E, Luminance of the GABABR which was significantly higher in Orx+ neurons (E1), and significantly lower in MCH+ neurons (E2) following SD compared to SC and SR. Note that the changes in GABARs on Orx neurons parallel the percentage wake, whereas those on MCH+ neurons parallel the percentage sleep across groups. *Indicates significant difference of SD relative to SC and SR (p < 0.05). §Indicates significant difference of SR relative to SC (p < 0.05), according to post hoc paired comparisons following one-way ANOVA (Table 1). Abbreviations: Lum, luminance.

GABAARs on Orx and MCH neurons after SD and SR

Triple-stained sections for GABAAR/FNS with either Orx or MCH were analyzed to assess the presence and intensity of GABAARs on Orx and MCH neurons across the three groups (SC, SD, and SR). GABAAR immunostaining appeared to be located on the plasma membrane of the Orx and MCH neurons, as well as that of other surrounding neurons (Figs. 2, 3).

GABAAR immunostaining was minimal and patch-like on the plasma membrane of the Orx-positive (+) neurons, whereas it was often moderate and continuous on the membrane of surrounding Orx-negative neurons in the same sections (Fig. 2). Though minimal on the Orx+ neurons, the GABAAR immunostaining appeared to be more intense after SD compared to that after SC or SR (Fig. 2A-C). The average proportion of the Orx+ neurons, which appeared positively immunostained (+) for GABAARs on the membrane was significantly greater in the SD group (48.45 ± 4.09%, n = 6 mice) compared to that in the SC and SR groups (23.93 ± 3.74%, n = 3 and 26.93 ± 4.37%, n = 3, respectively; Fig. 1B1; Table 1). The average luminance of the GABAAR immunostaining on the Orx+ neurons was also significantly higher in SD (58.71 ± 2.90, n = 60 cells) than in SC and SR groups (46.4 ± 3.42, n = 30 and 43.17 ± 2.56, n = 28, respectively; Fig. 1C1; Table 1). The luminance measures did not differ between SC and SR, indicating that the GABAAR returned to control or baseline levels during SR.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

GABAARs in Orx neurons across groups. Confocal images of immunostained sections indicate that the GABAAR (red) was minimal on Orx+ neurons (blue, indicated by filled arrowheads) compared to that on adjacent Orx-negative neurons (stained with FNS, green, indicated by carets). A, The GABAAR immunofluorescence was minimally visible as small clusters along a portion of the plasma membrane of an Orx+ cell body in an SC mouse, in which it was readily visible along the full membrane of an Orx-negative cell body. B, The GABAAR staining was more visible as larger clusters along a larger portion of the membrane of an Orx+ cell in an SD mouse. C, The GABAAR staining was similar in an SR mouse to that in SC. Scale bars, 10μm. Image thickness: A, B, 1500 nm; C, 2000 nm.

GABAAR immunostaining appeared to be relatively continuous around the plasma membrane of the MCH+ neurons and somewhat more intense compared to that on Orx+ neurons (Fig. 3). Moreover, the GABAAR immunostaining on the MCH+ neurons appeared to be moderate in the SC and SR groups (Fig. 3A–C). In contrast, it appeared minimal following SD, even though it was prominent on surrounding MCH-negative neurons (Fig. 3B). The average proportion of MCH+ neurons that appeared GABAAR+ decreased, though not significantly so, following SD (42.86 ± 6.40%, n = 6 mice) compared with SC and SR (54.38 ± 3.74%, n = 3 and 55.7 ± 2.55%, n = 3 respectively; Fig. 1B2; Table 1). The average luminance of the GABAAR on the MCH+ neurons decreased significantly after SD (34.43 ± 2.45, n = 60 cells) compared SC and SR (45.95 ± 3.31, n = 30 and 44.95 ± 2.59, n = 30, respectively; Fig. 1C2; Table 1). The measures did not differ between SC and SR, indicating that the GABAAR returned to control or baseline levels during SR.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

GABAARs in MCH neurons across groups. Confocal images indicate that GABAAR immunostaining (red) was moderate in MCH neurons (blue, indicated by filled arrowheads) though less than that in some adjacent MCH-negative neurons (stained with FNS, green, indicated by carets). A, GABAAR immunostaining was present as clusters visible along the full plasma membrane of the cell body in an SC mouse. B, GABAAR immunostaining was barely visible on MCH+ neurons, whereas it was prominent on adjacent MCH-negative neuron in an SD mouse. C, GABAAR immunostaining appeared to be moderate in an SR mouse, similar to that in SC. Scale bars, 10μm. Image thickness, 500 nm.

GABABRs on Orx and MCH neurons after SD and SR

Triple-staining for GABABR/FNS and either Orx or MCH was performed to examine the incidence of GABABRs on Orx or MCH neurons across the three groups (SC, SD, and SR). GABABR immunostaining appeared to be predominantly located over the cytoplasm of the cells, whereas only minimally located on the membrane of both the Orx and MCH neurons (Figs. 4, 5).

In the Orx+ neurons, GABABR immunostaining was prominent in the soma and proximal dendrites and appeared to be more dense and intense after SD than after SC and SR (Fig. 4A–C). Nonetheless, all Orx+ neurons (100%) were judged to be positively immunostained for the GABABR in all mice of all groups (n = 4 in SC and SR groups, n = 5 in SD group; Fig. 1D1; Table 1). On the other hand, the luminance of the GABABR in the Orx neurons was significantly higher following SD (22.84 ± 1.35, n = 50 cells) compared with SC and SR (14.36 ± 1.21, n = 40 and 14.76 ± 1.03, n = 40, respectively; Fig. 1E1; Table 1). The luminance did not differ between SC and SR, indicating that the GABABR returned to control or baseline levels during SR.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

GABABRs in Orx neurons across groups. Confocal images of the GABABR immunostaining (red) in Orx neurons (blue, indicated by filled arrowheads). A, The GABABR immunofluorescence was minimally visible as clusters over the cytoplasm of an Orx+ cell body in an SC mouse. B, The GABABR staining was more visible as larger clusters over the cytoplasm and partially on the plasma membrane of an Orx+ cell in an SD mouse. C, The GABABR staining was similar in an SR mouse to that in SC. Scale bars, 10μm. Image thickness, 1500 nm.

In the MCH+ neurons, GABABR immunostaining was prominent in the soma and appeared to be more dense following SC and SR than after SD (Fig. 5A–C). As for the Orx+ neurons, GABABR immunostaining was nonetheless judged to be positive in all MCH+ neurons (100%) and in every group (n = 4 in SC and SR groups, n = 5 in SD group; Fig. 1D2; Table 1). On the other hand, the luminance of GABABR immunostaining on the MCH+ neurons was significantly lower after SD (24.53 ± 1.59, n = 50 cells) compared with SC and SR (43.24 ± 2.87, n = 40 and 44.92 ± 2.33, n = 40, respectively; Fig. 1E2; Table 1). The luminance did not differ between SC and SR, indicating that the GABABR returned to control or baseline levels during SR.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

GABABRs in MCH neurons across groups. Confocal images of the GABABR immunostaining (red) in MCH neurons (blue, indicated by filled arrowheads). A, GABABR immunostaining was present as prominent large clusters over the cytoplasm of an MCH+ neuron in an SC mouse. B, The GABABR immunostaining was minimally visible over the cytoplasm of an MCH+ neuron in an SD mouse. C, The GABABR immunostaining appeared to be prominent over the cytoplasm and near the plasma membrane of an SR mouse, similar to that in SC. Scale bars, 10μm. Image thickness: A, 2000 nm; B, C, 1500 nm.

Discussion

The present results indicate that GABAA and GABAB receptors undergo dynamic and differential changes on Orx, wake-active and MCH, sleep-active neurons as a function of SD and thus their homeostatic response to different activity changes.

GABAARs differentially expressed as a function of sleep–wake activity

SD during the day, when mice normally sleep the majority of the time, resulted in increased GABAAR labeling on the membrane of the Orx neurons presumably due to prolonged activity by the Orx neurons during enforced waking, as indicated by previous c-Fos and recording studies (Lee et al., 2005; Modirrousta et al., 2005). The Orx neurons show changes in GABAARs that are parallel to those for cholinergic basal forebrain neurons following SD, when those neurons are also active, as indicated by c-Fos expression (Modirrousta et al., 2007). In addition, in the whole hypothalamus, mRNA expression for GABAAR (β-subunits) is also increased after SD and high activity periods (Volgin et al., 2014). In contrast, however, SD resulted in decreased GABAAR labeling on the membrane of MCH neurons here, presumably due to silence of the MCH neurons during waking, as indicated in previous c-Fos and recording studies (Verret et al., 2003; Modirrousta et al., 2005; Hassani et al., 2009). The changes in GABAAR density on the membrane seen here in the Orx and MCH neurons are similar to those described in cultured hippocampal neurons following pharmacologically induced firing and silencing, respectively (Kilman et al., 2002; Marty et al., 2004). These changes in the density of GABAAR clusters in the cultured neurons were moreover associated with increased versus decreased amplitude of miniature mIPSCs. An increase in membrane GABAARs was also shown to occur in hippocampal neurons in vivo after increased activity induced by seizures and was associated with an increase in IPSCs (Nusser et al., 1998). This increase in postsynaptic receptors appears to be the most effective way by which the magnitude of inhibitory transmission is increased (Mody et al., 1994). Somewhat similar to ours, another study in mice showed that GABAAR immunostaining (for the α1 subunit) was enhanced and that the sensitivity to a GABAAR agonist was increased along with the amplitude of IPSCs in Orx neurons following 6 h SD (Matsuki et al., 2015). The latter along with our results for the Orx neurons would appear to differ from those in rats showing increased amplitude of miniature EPSCs (mEPSCs) in Orx neurons following 4 h SD (Rao et al., 2007). However, the latter in vitro or ex vivo study was done in the presence of a GABAAR blocker (bicuculline) which did not allow assessment of changes in GABAAR currents and their potential influence on the mEPSCs. We can only assume that the increased activity by the Orx neurons during prolonged enforced waking stimulates homeostatic downscaling through increases in membrane GABAARs, which would render the neurons more susceptible and responsive to inhibition by GABA. Reciprocally, the prolonged absence of activity by the MCH neurons during prolonged waking stimulates homeostatic upscaling through decreases in membrane GABAARs, which would render them less susceptible and responsive to inhibition by GABA. The GABAARs returned to baseline levels with SR, indicating a return to normal levels of excitability and activity in both Orx and MCH cells.

GABABRs differentially expressed as a function of sleep–wake activity

With regard to the metabotropic GABABR receptor, we found that all of the Orx and MCH neurons showed positive immunostaining for that receptor across all groups. On the other hand, the density of the GABABR immunostaining appeared to differ according to cell type and group. By measurement of luminance, it was found that the intensity of GABABRs in Orx neurons increased with SD presumably due to enhanced and prolonged activity with enforced waking, whereas that in MCH neurons decreased with SD, presumably due to prolonged silence. These results thus paralleled those of the GABAAR. In the case of the GABABR, however, the immunostaining was most prominent in the cytoplasm and less evident on the plasma membrane. Although we did see staining along the membrane in some cases, we did not have adequate resolution for differentiation and systematic assessment of the membrane staining across groups. We can only assume that the different densities of GABABRs with SD reflect different expression of the receptor in homeostatic response to different activities of the Orx and MCH neurons under the abnormal conditions of sustained waking during the day when mice normally sleep the majority of the time. As with the GABAARs, the density of GABABRs returned to SC levels with SR, presumably reflecting the re-establishment of stable levels of excitability and activity during recovery sleep for both the Orx and MCH cells. Evidence from cultured hippocampus has indicated that the GABABR is essential for homeostatic regulation of firing within hippocampal circuits through both presynaptic and postsynaptic mechanisms (Vertkin et al., 2015). Indeed, it has been known that genetic deletion of the GABABR results in runaway excitation within these and cortical circuits resulting in seizure activity (Schuler et al., 2001), and that seizure activity is followed by increases in GABABRs in hippocampal neurons (Straessle et al., 2003). Deletion of the GABABR also leads to disruption of the sleep–wake cycle in mice (Vienne et al., 2010). Fragmentation of the cycle also occurred in mice lacking GABABRs specifically on Orx neurons (Matsuki et al., 2009).

Role of GABA receptors in neuronal homeostasis and sleep–wake regulation

GABA receptors, particularly GABAARs, have been shown to play an important role in the homeostatic regulation of neuronal excitability as a function of activity (Turrigiano, 1999). Here, we present evidence that dynamic and differential changes in both GABAA and GABAB receptors after SD reflect homeostatic downscaling following prolonged activity by the wake-active, Orx neurons and upscaling following inactivity by the sleep-active, MCH neurons.

Both GABAA and GABAB receptors, along with GABA, are known to play an important role in sleep. Most hypnotic drugs act upon the benzodiazepine binding site of the GABAAR to enhance GABA-mediated currents (Wafford and Ebert, 2008; Winsky-Sommerer, 2009; Feren et al., 2011). Some, like anesthetic agents (eg, barbiturates), act directly upon the GABAAR ion channel (Franks, 2008). Interestingly, anesthesia with GABAAR agonists (eg, propofol) can actually serve in the homeostatic response to SD in place of natural sleep recovery (Tung and Mendelson, 2004). Reciprocally, SD lowers the threshold to anesthesia induction, likely due to homeostatic changes in the GABAAR. Gamma hydroxybutyrate (GHB) used in the treatment of narcolepsy with cataplexy acts upon the GABABR to consolidate sleep with low muscle tone during sleeping periods, such as to reduce narcoleptic attacks during the following waking period in humans and rodents (Xie et al., 2006; Vienne et al., 2010; Boscolo-Berto et al., 2012; Black et al., 2014). Moreover, GHB or its metabolite can alleviate the behavioral and physiological effects of sleep deprivation (Walsh et al., 2010). These results would also suggest that pharmacological effects upon the GABABR, as upon the GABAAR, can mimic the homeostatic effects of sleep. However, such pharmacological effects are rarely cell specific and thus can affect both wake- and sleep-active cell groups, which as we show here would normally undergo differential homeostatic changes in their GABA receptors depending upon their state selective activity.

Sleep is regulated in a homeostatic manner (Borbély and Achermann, 1999), whereby SD is compensated for by enhanced NREM or slow wave sleep and delta EEG activity along with increased REM sleep. Whereas Orx neurons normally promote waking and prevent sleep including importantly REM sleep with muscle atonia (Mieda et al., 2004; Adamanitidis et al., 2007; Tsunematsu et al., 2011) MCH neurons normally enhance sleep including importantly REM sleep with muscle atonia (Verret et al., 2003; Jego et al., 2013; Konadhode et al., 2013; Tsunematsu et al., 2014). The reciprocal changes in the inhibitory GABA receptors and presumed excitability and activity of the Orx and MCH neurons seen here with SD could thus underlie the homeostatic response of decreased arousal and increased sleepiness during deprivation and increased sleep, including REM sleep, during recovery.

We conclude that expression and density of both GABAA and GABAB receptors increase on Orx neurons because of prolonged activity and reciprocally decrease on MCH neurons because of prolonged inactivity during SD. These reciprocal changes in excitability of the Orx and MCH neurons could decrease arousal and increase sleepiness along with sleep pressure during SD. During SR, the GABA receptors return to baseline presumably returning the excitability and activity of the Orx and MCH neurons to stable levels and thus restoring normal arousal while removing sleep pressure.

Footnotes

  • ↵1 The authors report no conflict of interest.

  • ↵3 This work was supported by grants from the Canadian Institutes of Health Research (CIHR, MOP-82762 and MOP-130502) to B.E.J. We thank Lynda Mainville for technical assistance, Anton Plavski for contribution to behavioral experiments, and Thomas Stroh for imaging consultation.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L (2007) Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450:420–424. doi:10.1038/nature06310 pmid:17943086
    OpenUrlCrossRefPubMed
  2. ↵
    Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE (1992) The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neur 319:218–245. doi:10.1002/cne.903190204 pmid:1522246
    OpenUrlCrossRefPubMed
  3. ↵
    Black SW, Morairty SR, Chen TM, Leung AK, Wisor JP, Yamanaka A, Kilduff TS (2014) GABAB agonism promotes sleep and reduces cataplexy in murine narcolepsy. J Neurosci 34:6485–6494. doi:10.1523/JNEUROSCI.0080-8014.2014 pmid:24806675
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Bonino M, Cantino D, Sassoè-Pognetto M (1999) Cellular and subcellular localization of gamma-aminobutyric acidB receptors in the rat olfactory bulb. Neurosci Lett 274:195–198. pmid:10548423
    OpenUrlCrossRefPubMed
  5. ↵
    Borbély AA, Achermann P (1999) Sleep homeostasis and models of sleep regulation. J Biol Rhythms 14:557–568. pmid:10643753
    OpenUrlCrossRefPubMed
  6. ↵
    Boscolo-Berto R, Viel G, Montagnese S, Raduazzo DI, Ferrara SD, Dauvilliers Y (2012) Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 16:431–443. doi:10.1016/j.smrv.2011.09.001 pmid:22055895
    OpenUrlCrossRefPubMed
  7. ↵
    Broberger C, De Lecea L, Sutcliffe JG, Hökfelt T (1998) Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neur 402:460–474. pmid:9862321
    OpenUrlCrossRefPubMed
  8. ↵
    Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437–451. pmid:10481909
    OpenUrlCrossRefPubMed
  9. ↵
    de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd., Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322–327. doi:10.1073/pnas.95.1.322
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Eggermann E, Bayer L, Serafin M, Saint-Mleux B, Bernheim L, Machard D, Jones BE, Muhlethaler M (2003) The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 23:1557–1562.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Feren S, Schweitzer PK, Walsh JK (2011) Pharmacotherapy for insomnia. Handb Clin Neurol 99:747–762. doi:10.1016/B978-0-444-52007-52004.00005-9 pmid:21056226
    OpenUrlCrossRefPubMed
  12. ↵
    Filippov AK, Couve A, Pangalos MN, Walsh FS, Brown DA, Moss SJ (2000) Heteromeric assembly of GABABR1 and GABABR2 receptor subunits inhibits Ca2+ current in sympathetic neurons. J Neurosci 20:2867–2874. pmid:10751439
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Franks NP (2008) General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9:370–386. doi:10.1038/nrn2372 pmid:18425091
    OpenUrlCrossRefPubMed
  14. ↵
    Fritschy JM, Mohler H (1995) GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neur 359:154–194. doi:10.1002/cne.903590111 pmid:8557845
    OpenUrlCrossRefPubMed
  15. ↵
    Hassani OK, Lee MG, Jones BE (2009) Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc Natl Acad Sci U S A 106:2418–2422. doi:10.1073/pnas.0811400106 pmid:19188611
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Jego S, Glasgow SD, Herrera CG, Ekstrand M, Reed SJ, Boyce R, Friedman J, Burdakov D, Adamantidis AR (2013) Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus. Nat Neurosci 16:1637–1643. doi:10.1038/nn.3522 pmid:24056699
    OpenUrlCrossRefPubMed
  17. ↵
    Kilman V, van Rossum MC, Turrigiano GG (2002) Activity deprivation reduces miniature IPSC amplitude by decreasing the number of postsynaptic GABAA receptors clustered at neocortical synapses. J Neurosci 22:1328–1337. pmid:11850460
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Konadhode RR, Pelluru D, Blanco-Centurion C, Zayachkiversusky A, Liu M, Uhde T, Glen WB Jr., van den Pol AN, Mulholland PJ, Shiromani PJ (2013) Optogenetic stimulation of MCH neurons increases sleep. J Neurosci 33:10257–10263. doi:10.1523/JNEUROSCI.1225-13.2013 pmid:23785141
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Lee MG, Hassani OK, Jones BE (2005) Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25:6716–6720. doi:10.1523/JNEUROSCI.1887-05.2005 pmid:16014733
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Margeta-Mitrovic M, Mitrovic I, Riley RC, Jan LY, Basbaum AI (1999) Immunohistochemical localization of GABAB receptors in the rat central nervous system. J Comp Neur 405:299–321. pmid:10076927
    OpenUrlCrossRefPubMed
  21. ↵
    Marty S, Wehrlé R, Fritschy JM, Sotelo C (2004) Quantitative effects produced by modifications of neuronal activity on the size of GABAA receptor clusters in hippocampal slice cultures. Eur J Neurosci 20:427–440. doi:10.1111/j.1460-9568.2004.03491.x pmid:15233752
    OpenUrlCrossRefPubMed
  22. ↵
    Matsuki T, Takasu M, Hirose Y, Murakoshi N, Sinton CM, Motoike T, Yanagisawa M (2015) GABAA receptor-mediated input change on orexin neurons following sleep deprivation in mice. Neuroscience 284:217–224. doi:10.1016/j.neuroscience.2014.09.063 pmid:25286384
    OpenUrlCrossRefPubMed
  23. ↵
    Matsuki T, Nomiyama M, Takahira H, Hirashima N, Kunita S, Takahashi S, Yagami K, Kilduff TS, Bettler B, Yanagisawa M, Sakurai T (2009) Selective loss of GABAB receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc Natl Acad Sci U S A 106:4459–4464. doi:10.1073/pnas.0811126106 pmid:19246384
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 101:4649–4654. doi:10.1073/pnas.0400590101 pmid:19246384
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Modirrousta M, Mainville L, Jones BE (2005) Orexin and MCH neurons express c-Fos differently after sleep deprivation versus recovery and bear different adrenergic receptors. Eur J Neurosci 21:2807–2816. doi:10.1111/j.1460-9568.2005.04104.x pmid:15926928
    OpenUrlCrossRefPubMed
  26. ↵
    Modirrousta M, Mainville L, Jones BE (2007) Dynamic changes in GABAA receptors on basal forebrain cholinergic neurons following sleep deprivation and recovery. BMC Neurosci 8:15. doi:10.1186/1471-2202-8-15 pmid:17316437
    OpenUrlCrossRefPubMed
  27. ↵
    Mody I, De Koninck Y, Otis TS, Soltesz I (1994) Bridging the cleft at GABA synapses in the brain. Trends Neurosci 17:517–525. pmid:7532336
    OpenUrlCrossRefPubMed
  28. ↵
    Nusser Z, Hájos N, Somogyi P, Mody I (1998) Increased number of synaptic GABAA receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395:172–177. doi:10.1038/25999 pmid:9744275
    OpenUrlCrossRefPubMed
  29. ↵
    Peyron C, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991–997. doi:10.1038/79690
    OpenUrlCrossRefPubMed
  30. ↵
    Rao Y, Liu ZW, Borok E, Rabenstein RL, Shanabrough M, Lu M, Picciotto MR, Horvath TL, Gao XB (2007) Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. J Clin Invest 117:4022–4033. doi:10.1172/JCI32829 pmid:18060037
    OpenUrlCrossRefPubMed
  31. ↵
    Schuler V, Lüscher C, Blanchet C, Klix N, Sansig G, Klebs K, Schmutz M, Heid J, Gentry C, Urban L, Fox A, Spooren W, Jaton AL, Vigouret J, Pozza M, Kelly PH, Mosbacher J, Froestl W, Käslin E, Korn R, et al. (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABAB responses in mice lacking GABAB(1). Neuron 31:47–58. pmid:11498050
    OpenUrlCrossRefPubMed
  32. ↵
    Straessle A, Loup F, Arabadzisz D, Ohning GV, Fritschy JM (2003) Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy. Eur J Neurosci 18:2213–2226. pmid:14622182
    OpenUrlCrossRefPubMed
  33. ↵
    Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474. pmid:11055430
    OpenUrlCrossRefPubMed
  34. ↵
    Tsunematsu T, Kilduff TS, Boyden ES, Takahashi S, Tominaga M, Yamanaka A (2011) Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice. J Neurosci 31:10529–10539. pmid:21775598
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Tsunematsu T, Ueno T, Tabuchi S, Inutsuka A, Tanaka KF, Hasuwa H, Kilduff TS, Terao A, Yamanaka A (2014) Optogenetic manipulation of activity and temporally controlled cell-specific ablation reveal a role for MCH neurons in sleep/wake regulation. J Neurosci 34:6896–6909. pmid:24828644
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Tung A, Mendelson WB (2004) Anesthesia and sleep. Sleep Med Rev 8:213–225. doi:10.1016/j.smrv.2004.01.003 pmid:15144963
    OpenUrlCrossRefPubMed
  37. ↵
    Turrigiano GG (1999) Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same. Trends Neurosci 22:221–227. pmid:10322495
    OpenUrlCrossRefPubMed
  38. ↵
    Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB (1998) Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391:892–896. doi:10.1038/36103 pmid:9495341
    OpenUrlCrossRefPubMed
  39. ↵
    van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK (2004) Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42:635–652. pmid:15157424
    OpenUrlCrossRefPubMed
  40. ↵
    Verret L, Goutagny R, Fort P, Cagnon L, Salvert D, Leger L, Boissard R, Salin P, Peyron C, Luppi PH (2003) A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 4:19. doi:10.1186/1471-2202-4-19
    OpenUrlCrossRefPubMed
  41. ↵
    Vertkin I, Styr B, Slomowitz E, Ofir N, Shapira I, Berner D, Fedorova T, Laviv T, Barak-Broner N, Greitzer-Antes D, Gassmann M, Bettler B, Lotan I, Slutsky I (2015) GABAB receptor deficiency causes failure of neuronal homeostasis in hippocampal networks. Proc Natl Acad Sci U S A 112:E3291–3299. doi:10.1073/pnas.1424810112 pmid:26056260
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Vienne J, Bettler B, Franken P, Tafti M (2010) Differential effects of GABAB receptor subtypes, {gamma}-hydroxybutyric Acid, and Baclofen on EEG activity and sleep regulation. J Neurosci 30:14194–14204. doi:10.1523/JNEUROSCI.3145-10.2010 pmid:20962240
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Volgin DV, Lu JW, Stettner GM, Mann GL, Ross RJ, Morrison AR, Kubin L (2014) Time- and behavioral state-dependent changes in posterior hypothalamic GABAA receptors contribute to the regulation of sleep. PLoS One 9:e86545. doi:10.1371/journal.pone.0086545 pmid:24466145
    OpenUrlCrossRefPubMed
  44. ↵
    Wafford KA, Ebert B (2008) Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat Rev Drug Discov 7:530–540. doi:10.1038/nrd2464 pmid:18511929
    OpenUrlCrossRefPubMed
  45. ↵
    Walsh JK, Hall-Porter JM, Griffin KS, Dodson ER, Forst EH, Curry DT, Eisenstein RD, Schweitzer PK (2010) Enhancing slow wave sleep with sodium oxybate reduces the behavioral and physiological impact of sleep loss. Sleep 33:1217–1225. pmid:20857869
    OpenUrlPubMed
  46. ↵
    Wan Q, Xiong ZG, Man HY, Ackerley CA, Braunton J, Lu WY, Becker LE, MacDonald JF, Wang YT (1997) Recruitment of functional GABAA receptors to postsynaptic domains by insulin. Nature 388:686–690. doi:10.1038/41792 pmid:9262404
    OpenUrlCrossRefPubMed
  47. ↵
    Winsky-Sommerer R (2009) Role of GABAA receptors in the physiology and pharmacology of sleep. Eur J Neurosci 29:1779–1794. doi:10.1111/j.1460-9568.2009.06716.x pmid:19473233
    OpenUrlCrossRefPubMed
  48. ↵
    Xie X, Crowder TL, Yamanaka A, Morairty SR, Lewinter RD, Sakurai T, Kilduff TS (2006) GABAB receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J Physiol 574:399–414. doi:10.1113/jphysiol.2006.108266 pmid:16627567
    OpenUrlCrossRefPubMed

Synthesis

The decision was a result of the Reviewing Editor Rae Silver and the peer reviewers coming together and discussing their recommendations until a consensus was reached. A fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision is listed below. The following reviewers agreed to reveal their identity: Thomas Kilduff, Patrick Fuller

In this interesting paper the authors report on factors associated with the expression/density of GABA receptors on orexin and MCH neurons. The manuscript provides evidence that GABA receptors on orexin neurons are homeostatically upregulated during sleep deprivation (SD). In contrast, in MCH neurons, GABA receptors are downregulated during SD.

The results indicate that effects on receptors are both a function of, and reflects differential responses to the antecedent behavioral state. These findings are consistent with existing cfos and in vitro electrophysiological data (and where it does not, the authors provide sound explanation). While poised to make an important contribution to the literature, the paper could be strengthened by addressing a few concerns. Primary among these concerns is that insufficient details are provided concerning several aspects of the study, as follows:

MAJOR ISSUES

It is not clear how the neurons were selected for luminescent measurements. For example, what criteria were used to select cells? How was selection bias avoided? And was the selector blinded to the condition of the animals?

Why are there so few neurons chosen for luminescent measurements? And do the authors have evidence that the 8-10 neurons counted for each animal were representative of the entire population in a particular animal?

The number of mice in each of the 4 experimental groups is not mentioned. This is a critical detail because the two SD groups were combined (I. 172-173) into a single group comprised of 11 mice. It would also be useful to know how many mice in each group were implanted for EEG recording.

The two GABA receptor antibodies used in this study are identified but no characterization of these antisera is presented nor a reference to the literature in which they have been characterized nor even mention of any immunostaining controls that the authors conducted in the absence of the primary antibody.

Was the immunostained material batch processed?

MINOR ISSUES

What is the difference between the grid size and counting frame? Please clarify.

Please clarify which mice in which groups had EEG headstages.

The figures aren't labelled (i.e. figure 1,2,3 etc) in the merged file.

Describing MCH neurons as 'sleep-promoting' is a bit of a stretch, if possibly inaccurate. Several in vivo optogenetic papers regarding MCH neurons and REM sleep have been published over the past few years. And the one thing that all of these studies reach consensus on is that activation of MCH neurons (using physiological stimulation paradigms) increases REM sleep epoch, and rather modestly at that.

The following point might be amplified: Work from Barbara Jones' lab has also shown [recording in head-fixed prep with juxtacellular labeling post hoc] that MCH neurons fire maximally during REM sleep (paradoxical sleep), and only occasionally during NREM (SWS) sleep.

Electrophysiologically, 100% orexin neurons tested respond to muscimol (Eggermann 2003, Xie 2006).

Why do the authors think that the number of orexin neurons expressing GABA-A receptors is so low when measured using immunohistochemical methods?

Back to top

In this issue

eneuro: 3 (3)
eNeuro
Vol. 3, Issue 3
May/June 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
GABA Receptors on Orexin and Melanin-Concentrating Hormone Neurons Are Differentially Homeostatically Regulated Following Sleep Deprivation
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
GABA Receptors on Orexin and Melanin-Concentrating Hormone Neurons Are Differentially Homeostatically Regulated Following Sleep Deprivation
Hanieh Toossi, Esther del Cid-Pellitero, Barbara E. Jones
eNeuro 31 May 2016, 3 (3) ENEURO.0077-16.2016; DOI: 10.1523/ENEURO.0077-16.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
GABA Receptors on Orexin and Melanin-Concentrating Hormone Neurons Are Differentially Homeostatically Regulated Following Sleep Deprivation
Hanieh Toossi, Esther del Cid-Pellitero, Barbara E. Jones
eNeuro 31 May 2016, 3 (3) ENEURO.0077-16.2016; DOI: 10.1523/ENEURO.0077-16.2016
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • GABAAR
  • GABABR
  • homeostasis
  • mice
  • waking

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Integrative Systems

  • Functional connectome correlates of laterality preferences: Insights into Hand, Foot, and Eye Dominance Across the Lifespan
  • Alpha-Frequency Stimulation Enhances Synchronization of Alpha Oscillations with Default Mode Network Connectivity
  • Characteristics of Spontaneous Anterior–Posterior Oscillation-Frequency Convergences in the Alpha Band
Show more Integrative Systems

Subjects

  • Integrative Systems
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.